Lisinopril

Lisinopril
(IUPAC) ime
	N2-[(1S)-1-karboksi-3-fenilpropil]-L-lizil-L-prolin
Klinički podaci
Robne marke	Prinivil, Tensopril, Zestril, Hipril
AHFS/Drugs.com	Monografija
MedlinePlus	a692051
Identifikatori
CAS broj	83915-83-7
ATC kod	C09AA03
PubChem	5362119
DrugBank	APRD00560
ChemSpider	4514933
UNII	7Q3P4BS2FD
KEGG	D00362
ChEBI	CHEBI:43755
ChEMBL	CHEMBL1237
Hemijski podaci
Formula	C21H31N3O5
Mol. masa	405,488 g/mol
SMILES	eMolekuli & PubHem
Sinonimi	(2S)-1-[(2S)-6-amino-2[(1S)-1-karboksi-3-fenilpropil]amino}heksanoil]pirolidin-2-karboksilna kiselina
Farmakokinetički podaci
Bioraspoloživost	oko 25%
Vezivanje za proteine plazme	0
Metabolizam	None
Poluvreme eliminacije	12 sata
Izlučivanje	Eliminiše se nepromenje u urinu
Farmakoinformacioni podaci
Trudnoća	?
Pravni status	℞ Prescription only
Način primene	Oralno

Lisinopril je lek klase inhibitora angiotenzin konvertujućeg enzima (ACE). On se prvenstveno koristi u tretmanu hipertenzije, zatajenja srca, i srčanog udara, kao i za sprečavanje renalnih i retinalnih komplikacija uzrokovanih dijabetesom. Njegove indikacije, kontraindikacije i nuspojave su tipične za sve ACE inhibitore.

Kratke činjenice (IUPAC) ime, Klinički podaci ...

Zatvori

Istorijski, lisinopril je bio treći ACE inhibitor (nakon kaptoprila i enalaprila) i uveden je u upotrebu tokm ranih 1990-tih.^[6]

Više informacija Osobina, Vrednost ...

Osobina	Vrednost
Broj akceptora vodonika	7
Broj donora vodonika	4
Broj rotacionih veza	12
Particioni koeficijent^[7] (ALogP)	-3,7
Rastvorljivost^[8] (logS, log(mol/L))	-4,2
Polarna površina^[9] (PSA, Å²)	132,9

Zatvori

[1]
Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
[2]
Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
[3]
Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit
[4]
Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.
[5]
Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit
[6]
Patchett A, Harris E, Tristram E, Wyvratt M, Wu M, Taub D, Peterson E, Ikeler T, ten Broeke J, Payne L, Ondeyka D, Thorsett E, Greenlee W, Lohr N, Hoffsommer R, Joshua H, Ruyle W, Rothrock J, Aster S, Maycock A, Robinson F, Hirschmann R, Sweet C, Ulm E, Gross D, Vassil T, Stone C (1980). „A new class of angiotensin-converting enzyme inhibitors”. Nature 288 (5788): 280–3. DOI:10.1038/288280a0. PMID 6253826.
[7]
Ghose, A.K., Viswanadhan V.N., and Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”. J. Phys. Chem. A 102: 3762-3772. DOI:10.1021/jp980230o.
[8]
Tetko IV, Tanchuk VY, Kasheva TN, Villa AE. (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Chem Inf. Comput. Sci. 41: 1488-1493. DOI:10.1021/ci000392t. PMID 11749573. edit
[9]
Ertl P., Rohde B., Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”. J. Med. Chem. 43: 3714-3717. DOI:10.1021/jm000942e. PMID 11020286. edit

Fogari R, Zoppi A, Corradi L, Lazzari P, Mugellini A, Lusardi P (November 1998). „Comparative effects of lisinopril and losartan on insulin sensitivity in the treatment of non diabetic hypertensive patients”. Br J Clin Pharmacol 46 (5): 467–71. DOI:10.1046/j.1365-2125.1998.00811.x. PMC 1873694. PMID 9833600.
Bussien JP, Waeber B, Nussberger J, Gomez HJ, Brunner HR (1985). „Once-daily lisinopril in hypertensive patients: Effect on blood pressure and the renin-angiotensin system”. Curr Therap Res 37: 342–51.

Omapatrilat

[1] [1]
Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit

[2] [2]
Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.

[3] [3]
Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit

[4] [4]
Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.

[5] [5]
Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit

[6] [6]
Patchett A, Harris E, Tristram E, Wyvratt M, Wu M, Taub D, Peterson E, Ikeler T, ten Broeke J, Payne L, Ondeyka D, Thorsett E, Greenlee W, Lohr N, Hoffsommer R, Joshua H, Ruyle W, Rothrock J, Aster S, Maycock A, Robinson F, Hirschmann R, Sweet C, Ulm E, Gross D, Vassil T, Stone C (1980). „A new class of angiotensin-converting enzyme inhibitors”. Nature 288 (5788): 280–3. DOI:10.1038/288280a0. PMID 6253826.

[7] [7]
Ghose, A.K., Viswanadhan V.N., and Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”. J. Phys. Chem. A 102: 3762-3772. DOI:10.1021/jp980230o.

[8] [8]
Tetko IV, Tanchuk VY, Kasheva TN, Villa AE. (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Chem Inf. Comput. Sci. 41: 1488-1493. DOI:10.1021/ci000392t. PMID 11749573. edit

[9] [9]
Ertl P., Rohde B., Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”. J. Med. Chem. 43: 3714-3717. DOI:10.1021/jm000942e. PMID 11020286. edit

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]

Wikiwand in your browser!

Lisinopril

Wikiwand in your browser!

Osobine

Reference

Literatura

Povezano

Spoljašnje veze

(IUPAC) ime

N²-[(1S)-1-karboksi-3-fenilpropil]-L-lizil-L-prolin
Klinički podaci
Robne marke	Prinivil, Tensopril, Zestril, Hipril
AHFS/Drugs.com	Monografija
MedlinePlus	a692051
Identifikatori
CAS broj	83915-83-7
ATC kod	C09AA03
PubChem^[1]^[2]	5362119
DrugBank	APRD00560
ChemSpider^[3]	4514933
UNII	7Q3P4BS2FD^Y
KEGG^[4]	D00362^Y
ChEBI	CHEBI:43755^Y
ChEMBL^[5]	CHEMBL1237^Y
Hemijski podaci
Formula	C₂₁H₃₁N₃O₅
Mol. masa	405,488 g/mol
SMILES	eMolekuli & PubHem

Sinonimi	(2S)-1-[(2S)-6-amino-2[(1S)-1-karboksi-3-fenilpropil]amino}heksanoil]pirolidin-2-karboksilna kiselina
Farmakokinetički podaci
Bioraspoloživost	oko 25%
Vezivanje za proteine plazme	0
Metabolizam	None
Poluvreme eliminacije	12 sata
Izlučivanje	Eliminiše se nepromenje u urinu
Farmakoinformacioni podaci
Trudnoća	?
Pravni status	℞ Prescription only
Način primene	Oralno